Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,053 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Outcomes of Stereotactic Body Radiotherapy for Patients With Stage I Small-Cell Lung Cancer: Analysis of a Subset of the Japanese Radiological Society Multi-Institutional SBRT Study Group Database.
Shioyama Y, Onishi H, Takayama K, Matsuo Y, Takeda A, Yamashita H, Miyakawa A, Murakami N, Aoki M, Matsushita H, Matsumoto Y, Shibamoto Y; Japanese Radiological Society Multi-Institutional SBRT Study Group (JRS-SBRTSG). Shioyama Y, et al. Among authors: matsumoto y. Technol Cancer Res Treat. 2018 Jan 1;17:1533033818783904. doi: 10.1177/1533033818783904. Technol Cancer Res Treat. 2018. PMID: 29983096 Free PMC article.
Pulmonary Oligometastases Treated by Stereotactic Body Radiation Therapy: A Nationwide Survey of 1,378 Patients.
Niibe Y, Yamamoto T, Onishi H, Yamashita H, Katsui K, Matsumoto Y, Oh RJ, Aoki M, Shintani T, Yamada K, Kobayashi M, Ozaki M, Manabe Y, Yahara K, Nishikawa A, Kakuhara H, Yamamoto K, Inoue T, Takada YU, Nagata K, Suzuki O, Terahara A, Jingu K. Niibe Y, et al. Among authors: matsumoto y. Anticancer Res. 2020 Jan;40(1):393-399. doi: 10.21873/anticanres.13965. Anticancer Res. 2020. PMID: 31892592
Stereotactic body radiotherapy in patients with lung tumors composed of mainly ground-glass opacity.
Onishi H, Shioyama Y, Matsumoto Y, Shibamoto Y, Miyakawa A, Suzuki G, Nishimura Y, Sasaki R, Miyawaki D, Kuriyama K, Komiyama T, Marino K, Aoki S, Saito R, Araya M, Maehata Y, Nonaka H, Tominaga L, Saito M, Sano N, Yamada S. Onishi H, et al. Among authors: matsumoto y. J Radiat Res. 2020 May 22;61(3):426-430. doi: 10.1093/jrr/rraa015. J Radiat Res. 2020. PMID: 32219316 Free PMC article.
Factors related to primary cancer death and non-primary cancer death in patients treated with stereotactic body radiotherapy for pulmonary oligometastases.
Yamamoto T, Niibe Y, Matsumoto Y, Aoki M, Oh RJ, Ozaki M, Kobayashi M, Manabe Y, Shintani T, Dekura Y, Onishi H, Yamashita H, Jingu K. Yamamoto T, et al. Among authors: matsumoto y. Cancer Med. 2020 Dec;9(23):8902-8911. doi: 10.1002/cam4.3508. Epub 2020 Oct 6. Cancer Med. 2020. PMID: 33022899 Free PMC article.
Present clinical practices of stereotactic irradiation for metastatic brain tumors in Japan: results of questionnaire survey of the Japanese Radiation Oncology Study Group (JROSG) working subgroup for neurological tumors.
Harada K, Igaki H, Abe E, Ariga T, Hayashi N, Kanemoto A, Komiyama T, Matsumoto Y, Nakano T, Onimaru R, Saito H, Sumi M, Tago M, Tanaka K, Maebayashi K, Aoyama H; Japanese Radiation Oncology Study Group (JROSG) Working Subgroup for Neurological Tumors. Harada K, et al. Among authors: matsumoto y. Int J Clin Oncol. 2018 Dec;23(6):1015-1022. doi: 10.1007/s10147-018-1313-4. Epub 2018 Jul 3. Int J Clin Oncol. 2018. PMID: 29971621
6,053 results